Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
about
Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal systemPARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's diseaseActivity enhances dopaminergic long-duration response in Parkinson disease.Sex differences in Parkinson's diseaseEarly presymptomatic and long-term changes of rest activity cycles and cognitive behavior in a MPTP-monkey model of Parkinson's diseaseHarnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and ChallengesHow compensation breaks down in Parkinson's disease: Insights from modeling of denervated striatumPro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neuronsNeuroanatomical study of the A11 diencephalospinal pathway in the non-human primateEstrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.Response monitoring in de novo patients with Parkinson's diseaseQuantitative assessment of stereotyped and challenged locomotion after lesion of the striatum: a 3D kinematic study in rats.Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease.Functional brain networks and abnormal connectivity in the movement disorders.Functional brain networks in movement disorders: recent advancesEarly post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease.Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy.On a basal ganglia role in learning and rehearsing visual-motor associations.Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's diseaseReorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers.Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatumPathological basal ganglia activity in movement disorders.Compensatory regulation of dopamine after ablation of the tyrosine hydroxylase gene in the nigrostriatal projectionChanges in network activity with the progression of Parkinson's disease.Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET studyPre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates.Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice.Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensorsMetabolic brain networks in translational neurology: concepts and applications.A new mouse model to study compensatory mechanisms that support normal motor function in Parkinson's diseasePrefrontal Markers and Cognitive Performance Are Dissociated during Progressive Dopamine Lesion.A scale-free systems theory of motivation and addiction.Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia.Dynamic systems approaches and levels of analysis in the nervous system.Drug Insight: new drugs in development for Parkinson's disease.Cell therapy for Parkinson's disease: only young onset patients allowed? Reflections about the results of recent clinical trials with cell therapy and the progression of Parkinson's disease.Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson's Disease: Randomized TrialSynaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
P2860
Q21090220-4CD2E3C4-B37C-4285-9845-5747B277443DQ24294809-EC8CDC9F-1709-46CC-A85B-D3CF3F8A6999Q24630470-15E6B3C5-8A85-497D-B13E-A2AF82E34B02Q27025107-686096A7-4B53-4B4C-B251-A73F7C86D7A7Q27322880-A1A309D8-C4F2-4A01-857C-2FE6981862CBQ28072061-CE157A05-F005-44E3-A1D1-D7D359FA845BQ28078491-18BB1A6D-FE0C-4B9E-97B5-0C8199556335Q28473591-7AB14D9D-D3F7-489B-9B1E-B5A6025C055EQ28748883-6771DB7B-6F0B-48CE-9FBD-E4D7F7639778Q30478476-321AA9F0-05B7-457B-B22B-52529EE8C65FQ30650489-32470811-9164-43F6-918F-4F87B7576985Q33423006-0552562F-A78E-4E91-8D53-6F408B4F93B2Q33512918-29D4A518-BCF1-4484-B2D4-4288A0A3A715Q33835425-DACA7A2F-CE31-49E9-8077-E54525756E48Q34114125-F99D35BF-A469-428F-8F3A-B38E7323814AQ34308197-CED504F3-2DA6-4AD5-8FC8-0A29101ECC73Q34435195-48D9F635-FA3B-4302-AAC0-6ED8788F18E2Q34602175-15AC70F8-7388-4632-A593-59F7783FB5E4Q34725942-F33B0845-9205-45E5-AC66-DC6FFB8473D8Q34990529-8B5622E0-4B77-4964-8440-DE02D69D5673Q35106295-4B8D202B-92E0-4486-AE92-57F142BE422FQ35146588-ECD346B9-9BF3-4E9E-97F5-5DB9125B93B8Q35532146-1F9D9D97-8F53-4A7E-A49E-A1E6EDEC686AQ35604562-66D3079B-22A0-4804-8626-2888AAB2D353Q35679748-E276BB10-AC50-4021-B829-4E778CBEAD24Q35679768-A4D9C949-B0A7-44E3-96E3-067D55161E7AQ35690133-6BD3B92A-6097-4BCD-84AF-9558D9E4C67BQ35922870-7B207000-12B6-46A9-B371-4D7799B5A1C4Q35971342-73758615-EB07-495F-A24B-D60D5681709AQ36015547-C30447BB-0B47-4C06-A520-BE3119C84E39Q36041821-D6CDE07E-51BA-4469-94F8-7307EAAEA0B9Q36081736-7AD80806-49A8-4059-855A-843D00CB6F85Q36185520-5FFF9EF7-5DA3-41DA-A1AA-DA5782926294Q36293916-7A924E4C-F651-4D57-ABD6-F891C1683D87Q36510471-32A8AB99-4296-4FE9-8E3F-8B9AA4598DA2Q36586662-7A4CF022-79F1-4A64-BDA5-CE01A13A3B0FQ36631654-540399E9-8B6D-44D1-88EF-1AEFCCC46EACQ36660994-748D1993-DE2A-478F-9090-46B7979FB179Q36978670-AA88EEEC-C417-48C4-BD98-059C3902CF10Q37001804-6EC10FB3-A18B-409D-B186-CEF58B69915E
P2860
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
@ast
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
@en
type
label
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
@ast
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
@en
prefLabel
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
@ast
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
@en
P1476
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
@en
P2093
Christian E Gross
Erwan Bezard
P304
P356
10.1016/S0166-2236(03)00038-9
P577
2003-04-01T00:00:00Z